We are pleased to announce that our CEO, Pontus Rehn, will represent Simsen Diagnostics at the upcoming Ecosystem Exchange: Life Sciences 2025, hosted by the Swedish Chamber of Commerce for the UK. The event will take place on April 23rd, 2025, at Freeths London, located in the heart of London’s life sciences hub.
This prestigious event is designed to support innovative scaleups in Health-, Med-, Bio-, and Pharmatech, providing a unique platform for companies to accelerate growth, forge strategic partnerships, and gain expert insights into the UK life sciences ecosystem.
Strategic Importance of the Event
As a leader in ultra-sensitive ctDNA analysis, Simsen Diagnostics is committed to driving innovation in precision diagnostics. The Ecosystem Exchange: Life Sciences 2025 aligns perfectly with our mission by offering:
- Opportunities to network with top-tier industry leaders and experts.
- Access to masterclasses and inspirational sessions focused on navigating regulatory frameworks and market strategies in the UK.
- A chance to strengthen collaborations with key stakeholders in the life sciences sector.
This event is part of the Pioneer the Possible initiative, showcasing Swedish innovation and its contribution to solving global challenges, including sustainable solutions and transformative technologies. Our recent My Green Lab Certification (GREEN level) further reinforces our role as a sustainability leader in the life sciences sector, ensuring that innovation and environmental responsibility go hand in hand.
Meet Pontus Rehn
Pontus Rehn will engage with fellow participants during the event’s speed networking sessions and other interactive forums. If you are attending and wish to discuss our groundbreaking diagnostics technologies or explore partnership opportunities, we encourage you to connect with Pontus during the event or send an email to pontus.rehn@simsendiagnostics.com.
About Simsen Diagnostics
At Simsen Diagnostics, we are dedicated to pushing the boundaries of diagnostics with our cutting-edge ctDNA analysis solutions. Our participation in this event reflects our commitment to expanding our presence in the UK and contributing to the advancement of life sciences on a global scale.
